Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Medistep Healthcare IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 43  to  -- per share
Profile
Min Investment ₹--
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Our Company was originally incorporated on June 05, 2023 as ‘Medistep Healthcare Limited’, as a Public limited company under the Companies Act, 2013, pursuant to a certificate of incorporation issued by Registrar of Companies, Gujarat. The company operates in the pharmaceutical industry and is involved in the business of trading of pharmaceutical products, intimate care and hygiene products, surgical products & nutraceutical products and manufacturing of intimate and nutraceutical products. The company has strategically expanded its operations by acquiring the business of M/s MG Pharma, a proprietorship concern owned by one of our promoter, Ms. Prajapati Hetalben Girdharilal. This acquisition was executed through a business transfer agreement dated July 02, 2023. Following the agreement, the business of the sole proprietorship was integrated into Medistep Healthcare Limited. The Corporate Identification Number of Our Company is U21009GJ2023PLC141841. Read More

Basic Info

Face Value 10 per share

Price 43  to  -- per share

P/E (x) --

Sales( Cr.) 50

PAT( Cr.) 4

EPS 4

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Girdhari Lal Prajapat Dabhi Vipul Gobarbhai Prajapati Hetalben Girdharilal

Pre Issue Share Holding 93.62%

Post Issue Share Holding 68.96%

Listing Details:

Listing Price: 53

Listing Gain: 18.87%

Current Price: 18

Gain On Issue: 18 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Aug 08, 2025
Closing Date Aug 12, 2025
Allotment Aug 13, 2025
Refund Aug 14, 2025
Delivery of Shares Aug 14, 2025
Listing Date Aug 15, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 6000 --
Retail (Max) -- -- --
S-HNI (Min) 1 6000 --
S-HNI (Max) -- -- --
B-HNI (Min) 1 6000 --

Objective of the Issue

1. To meet out the capital expenditure for purchasing new plant and machineries for expansion at the existing manufacturing facility 2. To meet out the Working Capital requirements of the Company 3. To meet out the General Corporate Purposes 4. To meet out the Issue Expenses.

Issue

Category Nos Bid Bid (x)
QIB 0 24663000 0x
NII 0 489063000 0x
Retail 0 820428000 0x
EMP 0 0 0x
Total 0 1334154000 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Medistep Healthcare Profit & Loss

#(Fig in Cr.) Mar 2024 Mar 2025 TTM
Net Sales 32 50
Other Income 0 0
Total Income 32 50
Total Expenditure 28 44
Operating Profit 4 6
Interest 0 0
Depreciation 0 0
Exceptional Income / Expenses 0 0
Profit Before Tax 4 6
Provision for Tax 1 1
Profit After Tax 3 4
Adjustments 0 0
Profit After Adjustments 3 4
Adjusted Earnings Per Share 3 4

Medistep Healthcare Balance Sheet

#(Fig in Cr.) Mar 2024 Mar 2025
Shareholder's Funds 12 17
Minority's Interest 0 0
Borrowings 0 0
Other Non-Current Liabilities 0 0
Total Current Liabilities 3 6
Total Liabilities 15 23
Fixed Assets 0 0
Other Non-Current Assets 0 0
Total Current Assets 15 23
Total Assets 15 23

Medistep Healthcare Cash Flow

#(Fig in Cr.) Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0
Cash Flow from Operating Activities -7 0
Cash Flow from Investing Activities -0 0
Cash Flow from Financing Activities 7 1
Net Cash Inflow / Outflow -0 1
Closing Cash & Cash Equivalent 0 1

Medistep Healthcare Ratios

# Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.97 3.96
CEPS(Rs) 2.99 3.99
DPS(Rs) 0 0
Book NAV/Share(Rs) 11.93 16.09
Core EBITDA Margin(%) 12.54 11.3
EBIT Margin(%) 12.5 11.24
Pre Tax Margin(%) 12.32 11.15
PAT Margin (%) 9.22 8.35
Cash Profit Margin (%) 9.28 8.41
ROA(%) 19.49 21.85
ROE(%) 24.92 29.06
ROCE(%) 32.9 37.86
Receivable days 158.76 124.47
Inventory Days 10.72 7.44
Payable days 18.8 16.2
PER(x) 0 0
Price/Book(x) 0 0
Dividend Yield(%) 0 0
EV/Net Sales(x) 0.17 0.2
EV/Core EBITDA(x) 1.31 1.74
Net Sales Growth(%) 0 57.06
EBIT Growth(%) 0 41.22
PAT Growth(%) 0 42.24
EPS Growth(%) 0 33.18
Debt/Equity(x) 0.03 0.04
Current Ratio(x) 4.64 3.73
Quick Ratio(x) 4.35 3.55
Interest Cover(x) 66.22 127.74
Total Debt/Mcap(x) 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 56% 0% 0% 0%
Operating Profit CAGR 50% 0% 0% 0%
PAT CAGR 33% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 29% 27% 27% 27%
ROCE Average 38% 35% 35% 35%

Company Contact Information

Medistep Healthcare Ltd.

Jagriti Sharma

+91 87808 46963

Info@medistephc.com

05, S. No-245/ B, Plot-19 T. P. S. 56, Free Way Trade Center Nr. A- One Hotel, N. H.-8, Narol Gam

IPO Lead Manager(s)

Medistep Healthcare Ltd.

Fast Track Finsec Pvt Ltd.

Registrar Info

Medistep Healthcare Ltd.

Cameo Corporate Services Ltd

Subramanian Buildings No 1 , Club House Road,,Chennai

044-28460390/28460394

044-28460129

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp